Role of T lymphocytes in the pathogenesis of Chlamydia disease.
暂无分享,去创建一个
F. Eko | C. Black | J. Igietseme | C. Bandea | G. Ananaba | D. Lyn | Kahaliah Joseph | A. Campbell | Q. He
[1] Ding Chen,et al. The Chlamydial Plasmid-Encoded Protein pgp3 Is Secreted into the Cytosol of Chlamydia-Infected Cells , 2008, Infection and Immunity.
[2] B. Arulanandam,et al. Antigen-Specific CD4+ T Cells Produce Sufficient IFN-γ to Mediate Robust Protective Immunity against Genital Chlamydia muridarum Infection1 , 2008, The Journal of Immunology.
[3] R. Brunham,et al. The arrested immunity hypothesis and the epidemiology of chlamydia control. , 2008, Sexually transmitted diseases.
[4] M. Umemura,et al. Interleukin‐17 as an Effector Molecule of Innate and Acquired Immunity against Infections , 2007, Microbiology and immunology.
[5] C. Andrews,et al. Plasmid-Deficient Chlamydia muridarum Fail to Induce Immune Pathology and Protect against Oviduct Disease1 , 2007, The Journal of Immunology.
[6] A. García-Sastre,et al. Live‐attenuated influenza viruses as delivery vectors for Chlamydia vaccines , 2007, Immunology.
[7] J. Lillard,et al. Host inflammatory response and development of complications of Chlamydia trachomatis genital infection in CCR5-deficient mice and subfertile women with the CCR5delta32 gene deletion. , 2005, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[8] R. Brunham,et al. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine , 2005, Nature Reviews Immunology.
[9] H. Thio,et al. Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] S. Fukuyama,et al. NALT- versus PEYER'S-patch-mediated mucosal immunity , 2004, Nature Reviews Immunology.
[11] Qing He,et al. Antibody regulation of T-cell immunity: implications for vaccine strategies against intracellular pathogens , 2004, Expert review of vaccines.
[12] Peri Nagappan,et al. Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. , 2003, The Journal of infectious diseases.
[13] R. Brunham,et al. Immunogenetic Correlates for Chlamydia trachomatis–Associated Tubal Infertility , 2003, Obstetrics and gynecology.
[14] F. Eko,et al. Contemporary approaches to designing and evaluating vaccines against Chlamydia , 2003, Expert review of vaccines.
[15] Robert E. Johnson,et al. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections -- 2002 , 2002 .
[16] H. Caldwell,et al. Immunity to Murine Chlamydial Genital Infection , 2002, Infection and Immunity.
[17] M. Starnbach,et al. T cell responses to Chlamydia trachomatis. , 2002, Current opinion in microbiology.
[18] G. Byrne,et al. Emerging strategies in the diagnosis, prevention and treatment of chlamydial infections , 2001 .
[19] W. Levine,et al. Effect of Chlamydia trachomatis coinfection on HIV shedding in genital tract secretions. , 2001, Sexually transmitted diseases.
[20] R. Stephens,et al. Chlamydia outer membrane protein discovery using genomics. , 2001, Current opinion in microbiology.
[21] R. Stephens. Chlamydial genomics and vaccine antigen discovery. , 2000, The Journal of infectious diseases.
[22] F. Eko,et al. Suppression of Endogenous IL-10 Gene Expression in Dendritic Cells Enhances Antigen Presentation for Specific Th1 Induction: Potential for Cellular Vaccine Development1 , 2000, The Journal of Immunology.
[23] W. Levine,et al. Estimated incidence and prevalence of genital Chlamydia trachomatis infections in the United States, 1996. , 1999, Sexually transmitted diseases.
[24] J. Penninger,et al. Chlamydia infections and heart disease linked through antigenic mimicry. , 1999, Science.
[25] R. Brunham,et al. Pathogenesis of Chlamydia induced pelvic inflammatory disease. , 1999, Sexually transmitted infections.
[26] R. Rank. Models of Immunity , 1999 .
[27] R. Stephens. Chlamydia: Intracellular Biology, Pathogenesis, And Immunity , 1999 .
[28] H. Caldwell,et al. Vaccination against Chlamydial Genital Tract Infection after Immunization with Dendritic Cells Pulsed Ex Vivo with Nonviable Chlamydiae , 1998, The Journal of experimental medicine.
[29] C. Black,et al. Route of Infection That Induces a High Intensity of Gamma Interferon-Secreting T Cells in the Genital Tract Produces Optimal Protection against Chlamydia trachomatis Infection in Mice , 1998, Infection and Immunity.
[30] A. Stagg,et al. Protection against Ascending Infection of the Genital Tract by Chlamydia trachomatis Is Associated with Recruitment of Major Histocompatibility Complex Class II Antigen-Presenting Cells into Uterine Tissue , 1998, Infection and Immunity.
[31] E. Peterson,et al. Factors influencing the induction of infertility in a mouse model of Chlamydia trachomatis ascending genital tract infection. , 1998, Journal of medical microbiology.
[32] H. Caldwell,et al. Distinct homing pathways direct T lymphocytes to the genital and intestinal mucosae in Chlamydia-infected mice. , 1998, Journal of immunology.
[33] E. Peterson,et al. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge , 1997, Infection and immunity.
[34] W. M. Mac Kenzie,et al. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. , 1997, American journal of obstetrics and gynecology.
[35] M. Russell,et al. Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system , 1997, Immunologic research.
[36] Michael de la Maza,et al. A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. , 1995 .
[37] L. M. de la Maza,et al. A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. , 1995, Vaccine.
[38] J. Paavonen. Chlamydia trachomatis--a major threat to reproduction. , 1993, European journal of obstetrics, gynecology, and reproductive biology.
[39] M. Jenkins,et al. Costimulating factors and signals relevant for antigen presenting cell function. , 1993, Advances in experimental medicine and biology.
[40] S. Thompson,et al. Pelvic Inflammatory Disease and Fertility: A Cohort Study of 1,844 Women with Laparoscopically Verified Disease and 657 Control Women with Normal Laparoscopic Results , 1992, Sexually transmitted diseases.
[41] D. Taylor-Robinson,et al. Genetic susceptibility to chlamydial salpingitis and subsequent infertility in mice. , 1992, Journal of reproduction and fertility.
[42] R. Rank,et al. Humoral immune response to chlamydial genital infection of mice with the agent of mouse pneumonitis , 1989, Infection and immunity.
[43] B. Katz,et al. Effect of Prior Sexually Transmitted Disease on the Isolation of Chlamydia trachomatis , 1987, Sexually transmitted diseases.
[44] U. Kees,et al. A method for testing the specificity of influenza A virus-reactive memory cytotoxic T lymphocyte (CTL) clones in limiting dilution cultures. , 1984, Journal of immunological methods.
[45] E. Puré,et al. 21 – Production of Lymphokines by Murine T Cells Grown in Limiting Dilution and Long-Term Cultures , 1982 .
[46] C. Fathman,et al. Isolation, characterization and utilization of T-lymphocyte clones edited by C. Garrison Fathman and Frank W. Fitch, Academic Press, 1982. £39.40/ $59.50 (xxviii + 549 pages) ISBN 0 122 49920 4. , 1983, Immunology today.